Experts recommend this because animal studies show possible harm to the fetus, and there isnt enough safety data in humans
For example, cotargeting IL-6/JAK/STAT3 signaling and the PD-1/PD-L1 axis may overcome immune resistance in PD-L1 high tumors with elevated IL-6
Key findings: weight loss, safety & tolerability, discontinuation The research revealed several significant insights: Greater weight loss with tirzepatide: Most adults with overweight or obesity experienced 5% or greater weight loss with either treatment
Description Quantity: 10 mg (lyophilised) 5-Amino-1MQ is a small-molecule compound studied for its ability to inhibit nicotinamide N-methyltransferase (NNMT)
A composite example from my practice: Ive cared for a patient maximized on both a DMARD and a biologic, still flaring several times a month, exhausted, in pain
In a study of semaglutide efficacy, the average reduction in weight from baseline was 10.2%, but 4.9% of patients achieved over 25% reduction from baseline, and 32.2% achieved less than a 5% reduction from baseline or even weight gain 5